Copy
Swiss Biobanking Platform – Newsletter N°2
View this email in your browser
NEWS ON SWISS BIOBANKING PLATFORM N°2
> SAVE THE DATE 
SBP will organize its first biobanking symposium in Lausanne on October 2nd, 2017. Stay tuned! Information will follow soon!
> Broad Consent for Research – Best Practices / Consultation 
Swiss Biobanking Platform as the implementing organ for the forthcoming national template developed Best Practices (PDF) to support the set up and appropriate use of Broad Consent for Research in the Swiss Institutions.

THE TEAM IS COMPLETE!

We welcomed our last collaborators in November 2016: three new hub coordinators in Bern, Zürich and St-Gallen joined the team.

You will find the updated organization chart on our website.

CONGRATULATIONS!

SBP congratulates the three grantees of the BioLink call which will partner with SBP to develop their IT strategy to build a network of their biobanks.

1) Prof. Peter J Wild (Digital Cancer Biobank, zBioLink)
2) Prof. Hoger Moch (PathoLink: Connecting biobanks to determine mechanisms of metastasis formation and chemoresistance)
3) Prof. Katharina Rentsch and Dr Adrian Egli (Biobanking for state-of-the-art Sepsis research)

WORKING GROUPS (WG) ON HARMONIZATION

ON DECEMBER 8th, 2016, SBP ORGANIZED ITS FIRST JOINT WG MEETING IN BERN. THIS GAVE THE OPPORTUNITY TO MANY OF THE SBP STAKEHOLDERS TO MEET EACH OTHER AND TO SHARE WG TRANSVERSAL VISION AND CHALLENGES.

TISSUE

The pathologies’ biobanks agreed to document the 7 preanalytics described in the Standardized PREanalytical Code (SPREC). The implementation is ongoing and includes cold and warm ischemia time. Preanalytical data link to samples will be defined in Q1 2017 to standardize and support the exchange of biomaterials and data. This WG is led by Prof. Aurel Perren.

MICROBIOLOGY

A new WG has been launched on February 14th 2017 with the objective to create a microbiology network in Switzerland. To that end, this WG is enlarged to representatives of Canton Hospitals and private laboratories in the field. This WG is led by Dr Adrian Egli from Basel University Hospital, investigator of the Sepsis biobank granted through SNSF BioLink call.

VETERINARY

Biobanks/collections linked to Vetsuisse in Bern and Zurich have been mapped. Currently, harmonization around the owner’s consent is in progress for the mapped biobanks. The integration of the further Vetsuisse collections is ongoing. This WG is led by Prof. Tosso Leeb.

LIQUID

Assessment on the practices of liquid biobanks and comparison with European specifications (CEN) is ongoing. While general recommendations on the different preanalytical steps will be issued in the course of 2017, the idea is to develop a database on preanalytical factors that can have an impact on the downstream application of samples. This tool would allow researchers to generate or control their SOPs in accordance to the future use of the biospecimens.
Prof. Carlo Largiadèr, director of the Liquid Biobank Bern at Inselspital leads this WG replacing Prof. Vincent Mooser since January 1st, 2017.

Feasibility study

Population based: A collaboration between the Federal Office of Public Health and SBP has been established to carry on the Human Biomonitoring Project (HBM). SBP will support HBM to be aligned with quality standards and will provide SBP the opportunity to implement its strategy into a proof-of-concept study. This project is led by Prof. Nicole Probst-Hensch.

Hospital-based: SBP plans to launch a call to select 5 projects which will support this feasibility study. Applications must be based on original, unique and timely scientific questions whose investigation critically depends on the networking of biobanks and the proper usage of biospecimens collected according to SBP guidelines. Details on this call will follow soon. This project is led by Prof. Vincent Mooser.

Biobank Information Management System (BIMS)

An internal database aggregating a dataset from multiple biobanks is currently under development in collaboration with the Swiss Institute of Bioinformatics (SIB). This database will provide samples’ availability and characteristics for sharing purposes.
A BIMS solution integrating a common module with a minimal dataset for biobanks is also under evaluation; this development will be initiated through the BioLink projects and should further be extended to other biobanks.

QUALITY

To anticipate the forthcoming ISO Standards - ISO/TC276, SBP will develop Guidelines for Good Biobanking Practices to harmonize Quality Management Systems. Besides, through its membership with the Swiss Association for Standardization (SNV), SBP participates in the drafting of the future ISO Standards.

For those who are interested, SBP will propose a tool to assess the organizational quality aspects of your biobank infrastructure.

GOVERNANCE

In October 2016, the World Medical Association (WMA) adopted the Declaration of Taipei on ethical considerations in Health Databases and Biobanks in Taipei, Taiwan. This Declaration is a strong incentive to support SBP actions. SBP as the responsible organ for biobank governance and national research consent implementation has developed Best Practices to support the setup of the forthcoming Broad Consent for Research in Swiss Institutions. Those Best Practices are under consultation along with the consent documents until March 31, 2017.

Copyright © 2017 Swiss Biobanking Platform, All rights reserved.


Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list